Consistently, further in vivo loss-of-function experiments demonstrated that Pin1 knockout had an inhibitory effect against hepatic steatosis, inflammation, insulin resistance, and fibrosis in NAFLD progression. The gene discussed is PIN1; the disease is metabolic dysfunction-associated steatotic liver disease.